Stock Ticker

  • Loading stock data...

Novan Inc (NASDAQ:NOVN) Recruits 525 Patients in the Phase 3 Clinical Trial to Treat Molluscum Contagiosum and Expects Topline Results in Q2 2021

Novan Inc (NASDAQ:NOVN) enrolled 525 patients for Simple4 Phase 3 clinical trial. It exceeds 60% enrollment of 825 patients and expects to complete the process in Q1 2021. Treatment for contagious skin infection The main aim of phase 3 clinical trial is to obtain topline efficacy results of the antiviral gel – SB206 to cure […]